Modulation of T Cell Immunity by TCR / pMHC Dwell Time and Activating / Inhibitory Receptor Pairs on the Antigen-Presenting Cell

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|3|233-244

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.3, 2003-01, pp. : 233-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of T-cell Mediated Immunity by Dopamine Receptor D5

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 2, 2013-06 ,pp. : 184-194

Bentham Science Publishers

Access to resources Recommend Favorite

T Cell Costimulatory and Inhibitory Receptors as Therapeutic Targets for Inducing Anti-Tumor Immunity

By  

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-02 ,pp. : 55-70

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma

By  

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2113-2116

Bentham Science Publishers

Access to resources Recommend Favorite

Augmenting T Helper Cell Immunity in Cancer

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 4, 2005-12 ,pp. : 365-371

Bentham Science Publishers

Access to resources Recommend Favorite

To make antibodies or not: signaling by the B-cell antigen receptor

By Gold M.R.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 7, 2002-07 ,pp. : 316-324

Elsevier

Access to resources Recommend Favorite